Prognostic and predictive relevance of microsatellite instability in colorectal cancer

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 241-249

  Storojeva, Iana ^a   Boulay, Jean Louis ^a   Heinimann, Karl ^a   Ballabeni, Pierluigi ^b   Terracciano, Luigi ^a   Laffer, Urban ^b   Muld, Gabriele ^a   Herrmann, Richard ^a   Rochlitz, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Adjuvant chemotherapy; Microsatellite instability; Mismatch repair genes; Randomized study

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; FLUOROURACIL; MICROSATELLITE DNA; MITOMYCIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; FEMALE; GENETICS; HUMAN; LITERATURE; MALE; META ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; MALE; META-ANALYSIS; MICROSATELLITE REPEATS; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REVIEW LITERATURE; SURVIVAL ANALYSIS;

EID: 24644515996     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J and Rockette H: Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03 and C-04). J Clin Oncol 17: 1349-1355, 1999. (Pubitemid 29220839)
2. Fielding LP, Hittinger R, Grace RH and Fry JS: Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet 340: 502-506, 1992.
3. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 17: 1356-1363, 1999.
4. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
5. Peltomaki P and Vasen HF: Mutations predisposing to hereditary non-polyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer. Gastroenterology 113: 1146-1158, 1997. (Pubitemid 27418968)
6. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B and Kinzler KW: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169-174, 1996. (Pubitemid 26057553)
7. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
8. Jass JR, Walsh MD, Barker M, Simms LA, Young J and Leggett B A: Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer 38: 858-866, 2002. (Pubitemid 34442312)
9. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP and de la Chapelle A: Incidence of hereditary non-polyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481-1487, 1998. (Pubitemid 28226275)
10. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Konishi F, Utsunomiya J and Miyaki M: Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307-317, 1996. (Pubitemid 26256718)
11. Shin KH, Shin JH, Kim JH and Park JG: Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary non-polyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germline mutations in promoter of the hMSH2 gene. Cancer Res 62: 38-42, 2002.
12. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, et al: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993. (Pubitemid 23167611)
13. Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, Green JS, Lynch HT, Watson P, Tallqvist G, Juhola M, et al: Replication errors in benign and malignant tumors from hereditary non-polyposis colorectal cancer patients. Cancer Res 54: 1645-1648, 1994. (Pubitemid 24116162)
14. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999. (Pubitemid 29354851)
15. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ and Thibodeau SN: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58: 3455-3460, 1998. (Pubitemid 28371090)
16. Feeley KM, Fullärd JF, Heneghan MA, Smith T, Maher M, Murphy RP and O'Gorman TA: Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis. J Pathol 188: 14-17, 1999. (Pubitemid 29197308)
17. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart I-J, Roche PC, McDonnell SK, Schaid DJ, Vockley CW, Michels VV, Farr GH and O'Connell MJ: Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58: 1713-1718, 1998. (Pubitemid 28215098)
18. Salahshor S, Kressner U, Fischer H, Lindmark G, Glimelius B, Pahlman L and Lindblom A: Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer 81: 190-193, 1999. (Pubitemid 29423694)
19. Kim H, Jen J, Vogelstein B and Hamilton SR: Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145: 148-156, 1994. (Pubitemid 24217493)
20. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A, et al: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853-5855, 1993. (Pubitemid 24006147)
21. Thibodeau SN, Bren G and Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260: 816-819, 1993. (Pubitemid 23167612)
22. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, et al: Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849-5852, 1993. (Pubitemid 24006146)
23. Curran B, Lenehan K, Mulcahy H, Tighe O, Bennett MA, Kay EW, O'Donoghue DP, Leader M and Croke DT: Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer. Gut 46: 200-204, 2000. (Pubitemid 30305845)
24. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowary EJ, Bull SB, Redston M and Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342: 69-77, 2000. (Pubitemid 30036597)
25. Lukish JR, Muro K, deNobile J, Katz R, Williams J, Cruess DF, Drucker W, Kirsch I and Hamilton SR: Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227: 51-56, 1998. (Pubitemid 28071337)
26. Hailing KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ, Witzig TE, Farr GH, Goldberg RM and Thibodeau SN: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91: 1295-1303, 1999. (Pubitemid 29387571)
27. Massa MJ, Iniesta P, Gonzalez-Quevedo R, de Juan C, Caldes T, Sanchez-Pernaute A, Cerdan J, Torres AJ, Balibrea JL and Benito M: Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer. Eur J Cancer 35: 1676-1682, 1999. (Pubitemid 30050639)
28. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M and Slattery ML: Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10: 917-923, 2001. (Pubitemid 32844897)
29. Gafa R, Maestri I, Matteuzzi M, Santini A, Ferretti S, Cavazzini L and Lanza G: Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer 89: 2025-2037, 2000.
30. Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD Morris RG, White S, Bird CC and Wyllie AH: Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer Oncogene 12: 2641-2649, 1996. (Pubitemid 26237793)
31. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M and Gallinger S: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349: 247-257, 2003. (Pubitemid 36859476)
32. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N and Iacopetta B: Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355: 1745-1750, 2000. (Pubitemid 30265078)
33. Messerini L, Ciantelli M, Baglioni S, Palomba A, Zampi G and Papi L: Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers. Hum Pathol 30: 629-634, 1999. (Pubitemid 29266720)
34. Ko JM, Cheung MH, Kwan MW, Wong CM, Lau KW, Tang CM and Lung ML: Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma. Int J Cancer 84: 404-409, 1999. (Pubitemid 29337128)
35. Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB III and Hamilton SR: Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344: 1196-1206, 2001. (Pubitemid 32319494)
36. Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA and Joensuu H: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119: 921-928, 2000.
37. Laffer U: Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK). Lancet 345: 349-353, 1995.
38. Klein JP: Survival Analysis. Springer Verlag, New York, 1997.
39. Therneau MM and Grambsch P: Modeling survival data. Springer Verlag, New York, 2000.
40. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993. (Pubitemid 23186645) Kantonsspital Basel